BSE filing, BSE: 543531. Summary written from the filing by ALFA Finder's alert engine.
Tierra Agrotech Ltd: key numbers
- Share price
- ₹29.00
- Market cap
- ₹190.2 Cr
- Revenue (annual)
- ₹98.47 Cr
- Net profit (annual)
- ₹-4.98 Cr
- P/E (TTM)
- -27.2×Sector 26.8×
- Promoter holding
- 9.34%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tierra Agrotech Ltd
All →Tierra Agrotech Other Announcement
Tierra Agrotech Ltd submitted a certificate from its Registrar confirming the non-applicability of Regulation 74(5) as all shares are held in dematerialized form.
Tierra Agrotech Annual General Meeting
Tierra Agrotech Ltd held its 13th Annual General Meeting on September 30, 2026. The proceedings and voting results have been formally submitted to the exchange.
Tierra Agrotech Merger & Restructuring
Tierra Agrotech Limited has decided to withdraw its previously proposed composite scheme of arrangement and amalgamation with Nishpra Community Solutions Private Limited.
Tierra Agrotech Annual General Meeting
Tierra Agrotech Limited has convened its 13th Annual General Meeting to be held on September 30, 2026, to conduct routine corporate business.
Tierra Agrotech Annual Report
Tierra Agrotech Ltd submitted its Annual Report for FY 2025-26. The 13th Annual General Meeting is scheduled for September 30, 2026.
Tierra Agrotech Management Change
Jayaram Prasad Munnangi has resigned as a Non-Executive Non-Independent Director of Tierra Agrotech Limited, effective September 1, 2026, citing personal commitments.
Other regulatory approval announcements
All →John Cockerill India Regulatory Approval
John Cockerill India received Reserve Bank of India approval for acquiring shares of John Cockerill Metals International SA. This allows the company to proceed with the share-swap acquisition.
Gland Pharma Regulatory Approval
Gland Pharma received USFDA approval for Methylprednisolone Acetate Injectable Suspension USP in multiple vial formats. The product is bioequivalent to Pfizer's Depo-Medrol in a ~$214M US market.
City Union Bank Regulatory Approval
City Union Bank disclosed RBI approval for appointing Shri Sankaran G as Executive Director (Whole-time Director) for three years. The board appointment and formal disclosures will follow later.
- Execution
- Three years from the date of taking charge
Lupin Regulatory Approval
Lupin received US FDA approval for its generic Amifampridine Tablets 10 mg ANDA. As a first-to-file applicant, it is eligible for 180-day shared generic exclusivity.
Som Distilleries & Breweries Regulatory Approval
Som Distilleries received manufacturing licences for its Bhopal plant from the Madhya Pradesh Excise Department, plus product label and rate approvals. Manufacturing and sales are expected to resume soon.
AGI Infra Regulatory Approval
Agi Infra received RERA registration PBRERA-SAS80-PR1452-102026 from Punjab RERA for its Utopia by AGI group housing project in New Chandigarh. The registration is valid until 30 March 2031.
- Execution
- Valid up to March 30, 2031